MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19.
MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. With patients enrolled for clinical trials for this vaccine, rapid development of the large-scale manufacturing process is a critical step in quickly and safely delivering it from the lab to … Continued
In the race to develop drugs and vaccines for COVID-19, MilliporeSigma rarely grabs any headlines, but it’s a critical supplier to companies that do. When you read about a lab working on a treatment for the coronavirus-caused disease, chances are good that it’s using reagents, or substances that cause chemical reactions, made by MilliporeSigma in St. Louis. Many vaccine scientists are … Continued
MilliporeSigma and The Jenner Institute today announced that the Institute has laid the foundation for large-scale production of its COVID-19 vaccine candidate, ChAdOx1 nCoV-19. Developing the manufacturing process itself would normally take at least six months to a year, but in just two months’ time, MilliporeSigma supported the Jenner team and their collaborators to evaluate … Continued